2 recruiting, 1 completed, 1 not yet recruiting. 2 Not applicable, 1 Early Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Not yet recruiting 1, Recruiting 1 |
| Early Phase 1 | 1 | Recruiting 1 |
| Phase 3 | 1 | Completed 1 |
Follow Macular Edema (ME): new trials by email Literature Review of Macular Edema (ME) trials Research Report on Macular Edema (ME)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Video Intervention to Improve Understanding of Diabetic Retinopathy at Zuckerberg San Francisco General Hospital and Trauma Center Animated Videos - Diabetic Retinopathy (DR), Macular Edema (ME) | Not applicable | Not yet recruiting | University of California, San Francisco | 150 | 2026-09-01 | 2026-07-22 |
| Minimal Vitrectomy Surgery for Epiretinal Membrane Minimal Vitrectomy Surgery, Conventional Vitrectomy - Epiretinal Membrane, Macular Edema (ME) | Not applicable | Recruiting | Peking Union Medical College Hospital | 140 | 2024-12-01 | 2025-06-13 |
| Suprachoroidal Triamcinolone in Macular Edema for Patients With Non-Infectious Uveitis Resistant to Subtenon Triamcinolon Suprachoroidal triamcinolone acetonide injection - Macular Edema (ME), Non Infectious Uveitis | Early Phase 1 | Recruiting | University of Baghdad | 20 | 2024-09-01 | 2025-08-28 |
| To Assess the Efficacy and Safety of Intravitreal Ranibizumab in People With Vision Loss Due to Macular Edema Sham control, Ranibizumab - Macular Edema (ME) | Phase 3 | Completed | Novartis Pharmaceuticals | 181 | 2013-10-01 | 2016-05-23 |
Macular Edema (4) · Diabetes Mellitus (1) · Diabetic Retinopathy (1) · Epiretinal Membrane (1) · Vision Disorders (1)
Eye Diseases (4) · Macular Degeneration (4) · Retinal Degeneration (4) · Retinal Diseases (4) · Cardiovascular Diseases (1) · Diabetes Complications (1) · Diabetic Angiopathies (1) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1) · Metabolic Diseases (1) · Nervous System Diseases (1) · Neurologic Manifestations (1) · Nutritional and Metabolic Diseases (1) · Pathological Conditions, Signs and Symptoms (1) · Sensation Disorders (1)
Ranibizumab (1)
Novartis Pharmaceuticals (1) · Peking Union Medical College Hospital (1) · University of Baghdad (1) · University of California, San Francisco (1)
Australia (1) · Belgium (1) · Canada (1) · China (1) · Czechia (1) · France (1) · Germany (1) · Hungary (1) · Iraq (1) · Israel (1) · Italy (1) · Latvia (1) · Netherlands (1) · Russia (1) · Singapore (1)
Sriranjani Padmanabhan, MD (1) · Weihong Yu, MD (1)